Cadila Healthcare Ltd's API manufacturing facility located at Ankleshwar (Unit 1), Gujarat has received an Establishment Inspection Report (EIR).
The USFDA had conducted an inspection at the facility from 22nd to 26th July 2019. The EIR report stated that the classification of the facility is 'No Action Indicated (NAI)'.
Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.247.25 as compared to the previous close of Rs. 237.75. The total number of shares traded during the day was 80546 in over 1321 trades.
The stock hit an intraday high of Rs. 249.4 and intraday low of 234.85. The net turnover during the day was Rs. 19627432.